Likert vs PI-RADS v2: a comparison of two radiological scoring systems for detection of clinically significant prostate cancer.

Christopher C Khoo David Eldred-EvansMax PetersMariana Bertoncelli TanakaMohamed NoureldinSaiful MiahTaimur ShahMartin J ConnorDeepika ReddyMartin ClarkAmish LakhaniAndrea RockallFeargus Hosking-JervisEmma CullenManit AryaDavid HroudaHasan QaziMathias WinklerHenry TamHashim Uddin Ahmed

Published in: BJU international (2019)

Both scoring systems demonstrated good diagnostic performance, with similar rates of decision to biopsy. Overall, Likert was superior by all definitions of clinically significant prostate cancer. It has the advantages of being flexible, intuitive and allowing inclusion of clinical data. However, its use should only be considered once radiologists have developed sufficient experience in reporting prostate mpMRI.

Keyphrases

prostate cancer
radical prostatectomy
electronic health record
artificial intelligence
ultrasound guided
adverse drug
emergency department
loop mediated isothermal amplification
decision making
machine learning
data analysis
drug induced